SCHEMBL8124398

SCHEMBL8124398

CCOC(=O)CCC(=O)c1c(C)cc2ccccn12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.66
HTT P42858 3/20 0.66
ATM Q13315 1/20 0.66
KDM4E B2RXH2 4/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 6/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 1/20 0.47
MAPK1 P28482 7/20 0.46
ALDH1A1 P00352 6/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 3/20 0.46
MEN1 O00255 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALOX12 P18054 1/20 0.46
LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11079665 0.83 KDM4E (0.58) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL11079422 0.81 L3MBTL1 (0.46) L3MBTL1HTTATMKDM4ESMN1; SMN2
SCHEMBL11076535 0.81 L3MBTL1 (0.46) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL11079333 0.81 HTT (0.46) L3MBTL1HTTATMKDM4ESMN1; SMN2
SCHEMBL1645738 0.80 L3MBTL1 (1.00) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL8122403 0.78 HTT (0.45) L3MBTL1HTTATMKDM4ESMN1; SMN2
SCHEMBL8123430 0.78 L3MBTL1 (0.54) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL4635494 0.77 L3MBTL1 (0.59) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL11185924 0.76 L3MBTL1 (0.46) L3MBTL1HTTATMKDM4ERAB9A
SCHEMBL27922094 0.75 L3MBTL1 (0.72) L3MBTL1HTTATMKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0519353-B1 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO (JP) 2000-08-16 EP disclosed
US-5334716-A Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-08-02 US disclosed
EP-0519353-A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-12-23 EP disclosed